Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04756479
Status:
COMPLETED
Last Update Posted:
2022-04-06
First Post:
2021-02-08
Brief Title:
Mortality Due to COVID-19 in the COVID-AGEBRU Study
Sponsor:
Brugmann University Hospital
Organization:
Brugmann University Hospital
Study Overview
Official Title:
Predictors of Intrahospital Mortality in Older Patients Admitted Due to COVID-19 in the COVID-19 AGEBRU Study
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COVID-AGEBRU
Brief Summary:
The COVID-Age Brugmann study aims to identify the clinical predictors of mortality risk in older patients admitted to an acute care unit due to COVID-19
Detailed Description:
The COVID-19 disease has been shown to be associated to higher mortality risk and health adverse consequences Despite of the fact that the SAR-COV2 virus has been shown that affects every populations the negative impact is higher in older people pointing this population as the most severely affected
The COVID-Age Brugmann study aims to identify if comorbidity geriatric syndromes and health issues at admission are associated to mortality risk in older patients admitted to an acute care unit due to COVID-19
The COVID-Age Brugmann study aims to identify if comorbidity geriatric syndromes and health issues at admission are associated to mortality risk in older patients admitted to an acute care unit due to COVID-19
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None